Company Overview of Amulet Pharmaceuticals, Inc.
Amulet Pharmaceuticals, Inc., a biotechnology company, develops nitric oxide based technologies for safety of cardiovascular stents, medical devices, and drugs. Its nitric oxide technology and products are used in coronary and peripheral vascular drug eluting stents, implantable medical devices, wounds, diabetes therapeutics, pain therapeutics, glaucoma, and self-disinfecting contact lenses and cases. The company was founded in 2001 and is headquartered in Rockville, Maryland.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2001
Key Executives for Amulet Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Amulet Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.